Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$84.76
pos +0.52
+0.62%
Today's Range: 84.04 - 85.00 | LLY Avg Daily Volume: 4,028,800
Last Update: 03/28/17 - 3:59 PM EDT
Volume: 2,754,894
YTD Performance: 14.53%
Open: $84.27
Previous Close: $84.24
52 Week Range: $64.18 - $86.14
Oustanding Shares: 1,103,354,357
Market Cap: 92,880,369,772
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 12
Moderate Buy 2 2 2 0
Hold 4 3 3 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.71 1.64 1.64 1.71
Latest Dividend: 0.52
Latest Dividend Yield: 2.47%
Dividend Ex-Date: 02/13/17
Price Earnings Ratio: 32.63
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
32.63 32.60 30.30
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.13% 18.45% 46.43%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.30 -0.10 -0.03
Net Income 13.70 -0.40 -0.16
EPS 14.20 -0.40 -0.16
Earnings for LLY:
EBITDA 5.34B
Revenue 21.22B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $0.95 $1.01 $4.10 $4.37
Number of Analysts 6 5 10 8
High Estimate $0.99 $1.07 $4.17 $4.50
Low Estimate $0.86 $0.88 $4.03 $4.09
Prior Year $0.83 $0.86 $3.52 $4.10
Growth Rate (Year over Year) 14.46% 17.21% 16.48% 6.62%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Doug Kass

 | Mar 28, 2017 | 5:13 PM EDT
Let me teach you how to Dougie.
RMPIA
By

Jim Cramer

 | Mar 23, 2017 | 3:16 PM EDT
Get your plan in place, but understand that the Republic is not in jeopardy.
RMPIA
By

Doug Kass

 | Mar 15, 2017 | 5:23 PM EDT
"I had nothing to offer anybody except my own confusion." -- Jack Kerouac 
RMPIA
By

Doug Kass

 | Mar 8, 2017 | 3:59 PM EST
 
By

Bruce Kamich

 | Mar 7, 2017 | 3:00 PM EST
Traders should look to go long on a close above $84.
RMPIA
By

Jim Cramer

 | Mar 7, 2017 | 2:00 PM EST
Drug companies are the latest targets/beneficiaries.

updateCowen Health Care Conf.

Mar 7, 2017 | 7:09 AM EST
Thomson ONE
Cowen Health Care Conference (Day 2 of 3) - 03/06/17 - 03/08/17 Boston, MA
RMPIA
By

Jim Cramer

 | Mar 6, 2017 | 6:50 AM EST
Bull market number one, perhaps of all time: the financials.
By

Jim Cramer

 | Feb 28, 2017 | 11:30 AM EST
Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.
RMPIA
By

Jim Cramer

 | Feb 22, 2017 | 11:45 AM EST
Icahn may have a tough time finding interest in this behemoth.
Shares of Coach appear to be back in rally mode today. The stock is up over 2.25%(Ka...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.